PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.55%
Negative revenue growth while EXP stands at 27.69%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-46.45%
Negative gross profit growth while EXP is at 56.14%. Joel Greenblatt would examine cost competitiveness or demand decline.
-97.89%
Negative EBIT growth while EXP is at 67.30%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-97.89%
Negative operating income growth while EXP is at 67.30%. Joel Greenblatt would press for urgent turnaround measures.
-88.18%
Negative net income growth while EXP stands at 73.60%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-88.32%
Negative EPS growth while EXP is at 75.66%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-88.32%
Negative diluted EPS growth while EXP is at 75.89%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.85%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.06%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-135.43%
Negative OCF growth while EXP is at 109.24%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-181.94%
Negative FCF growth while EXP is at 221.70%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
9.79%
10Y revenue/share CAGR under 50% of EXP's 235.47%. Michael Burry would suspect a lasting competitive disadvantage.
9.79%
5Y revenue/share CAGR under 50% of EXP's 113.60%. Michael Burry would suspect a significant competitive gap or product weakness.
9.79%
3Y revenue/share CAGR under 50% of EXP's 59.39%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-14.61%
Negative 10Y OCF/share CAGR while EXP stands at 382.98%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-14.61%
Negative 5Y OCF/share CAGR while EXP is at 240.23%. Joel Greenblatt would question the firm’s operational model or cost structure.
-14.61%
Negative 3Y OCF/share CAGR while EXP stands at 48.71%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
547.47%
Net income/share CAGR 1.25-1.5x EXP's 420.82%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
547.47%
5Y net income/share CAGR above 1.5x EXP's 321.40%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
547.47%
3Y net income/share CAGR above 1.5x EXP's 74.92%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
4.46%
Below 50% of EXP's 128.31%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
4.46%
Below 50% of EXP's 66.47%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
4.46%
Below 50% of EXP's 20.96%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.46%
AR growth is negative/stable vs. EXP's 32.01%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
7.64%
We show growth while EXP is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.39%
Negative asset growth while EXP invests at 2.02%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.23%
We have a declining book value while EXP shows 4.25%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
7.87%
Debt growth far above EXP's 0.52%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-12.59%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.